Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
Collection content
305 result(s) found, displaying 11 to 20
-
GuidanceGuidance relating to the supply of in vitro diagnostic medical devices for the detection of COVID-19/SARS-CoV-2 infections.
-
GuidanceGuidance clarifying the interaction between our requirements and AHPRA advertising guidelines.
-
PageAnswers to frequently asked questions in relation to rapid antigen point-of-care tests.
-
PageBatch release testing of biological medicines (excluding vaccines) is no longer required.
-
PageTo enable timely distribution of COVID-19 treatments, international labels may be used during initial supply in Australia.
-
PageInformation to assist businesses understand the key considerations for the safe implementation of COVID-19 rapid antigen point-of-care testing in their workplace.
-
PageExplore FAQs for new sponsors about the supply of disinfectant products.
-
GuidanceGuidance to assist manufacturers of medical devices and their component parts with meeting their regulatory obligations.
-
PageWe have identified disinfectants as being critical in preventing the spread of COVID-19. This information provides advice on how to use disinfectants properly.
-
PageUnderstand how disinfectants are regulated and how to supply them.